scholarly article | Q13442814 |
P819 | ADS bibcode | 1990PNAS...87.3624M |
P356 | DOI | 10.1073/PNAS.87.9.3624 |
P932 | PMC publication ID | 53954 |
P698 | PubMed publication ID | 2333305 |
P5875 | ResearchGate publication ID | 20823392 |
P2093 | author name string | Garcia-Blanco MA | |
Sharp PA | |||
Marciniak RA | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 | ||
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells | Q33556101 | ||
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. | Q34161762 | ||
The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region | Q34284937 | ||
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA | Q34311433 | ||
Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events | Q34344850 | ||
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
Some simple computational methods to improve the folding of large RNAs | Q35532878 | ||
Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. | Q35864756 | ||
trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. | Q36832567 | ||
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 | ||
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
HIV TAR: an RNA enhancer? | Q38708348 | ||
Regulation of HIV and HTLV gene expression | Q39289382 | ||
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat | Q40129795 | ||
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
A 64 kd nuclear protein binds to RNA segments that include the AAUAAA polyadenylation motif | Q41862487 | ||
Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism | Q42158761 | ||
HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
Tat protein from human immunodeficiency virus forms a metal-linked dimer | Q45841752 | ||
Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
Photo-induced joining of a transfer RNA with its cognate aminoacyl-transfer RNA synthetase | Q47854784 | ||
Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate | Q64380630 | ||
Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns | Q69314080 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3624-3628 | |
P577 | publication date | 1990-05-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus | |
P478 | volume | 87 |
Q38338631 | A 62,000 molecular weight spliceosome protein crosslinks to the intron polypyrimidine tract |
Q37343356 | A 69-kDa RNA-binding protein from Xenopus oocytes recognizes a common motif in two vegetally localized maternal mRNAs |
Q35227509 | A Comparison of Regulatory Features in Primate Lentiviruses |
Q36740883 | A heat-labile factor promotes premature 3' end formation in exon 1 of the murine adenosine deaminase gene in a cell-free transcription system |
Q39872176 | A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. |
Q36829057 | A minimal lentivirus Tat |
Q34597244 | A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity |
Q39717672 | A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription |
Q28247468 | Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein |
Q40060891 | An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat |
Q35829302 | An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy |
Q41532091 | Analysis of 3' terminals of human immunodeficiency virus type 1 transcripts in persistently infected cells |
Q41079020 | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. |
Q36828521 | Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation |
Q39070782 | Aptamers as Therapeutics |
Q36978919 | Aptamers as molecular recognition elements for electrical nanobiosensors |
Q33389174 | Aptamers: the emerging class of future anticoagulation for vascular disease |
Q36692947 | Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA |
Q48826334 | Brain specific proteins binding to the 3' UTR of the 5-HT2C receptor mRNA. |
Q35882320 | CAG trinucleotide RNA repeats interact with RNA-binding proteins |
Q28342742 | Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 |
Q41576182 | Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. |
Q37251783 | Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator |
Q36697484 | Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure |
Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
Q35792991 | Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains |
Q36636851 | Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. |
Q41139329 | Effect of RNA secondary structure on polyadenylation site selection |
Q40041905 | Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. |
Q36633736 | Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. |
Q37633114 | Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. |
Q45765531 | Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells |
Q24655684 | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat |
Q33992464 | Gene therapy for infectious diseases |
Q40045693 | Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. |
Q37056955 | Genetic regulation of human immunodeficiency virus. |
Q35937536 | HIV-1 Tat protein promotes formation of more-processive elongation complexes |
Q41234955 | HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure |
Q35928622 | Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation |
Q89522955 | Human Tat-specific factor 1 binds the HIV-1 genome and selectively transports HIV-1 RNAs |
Q36783325 | Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells |
Q40066208 | Human immunodeficiency virus type 1 Tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. |
Q37709787 | Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. |
Q36398874 | Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro |
Q40067137 | Identification and characterization of the bovine immunodeficiency-like virus tat gene |
Q40230497 | Identification of a novel HIV-1 TAR RNA bulge binding protein |
Q40066797 | Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras |
Q37775492 | In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. |
Q35019436 | In vivo selection of randomly mutated retroviral genomes |
Q35057947 | Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents. |
Q24568329 | Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies |
Q36618678 | Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences |
Q36638137 | Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. |
Q39880793 | Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists |
Q35845299 | Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes |
Q24671522 | Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator |
Q37603547 | Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter |
Q24645620 | La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA |
Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
Q28290464 | Molecular Cloning and Characterization of a TAR-Binding Nuclear Factor from T Cells |
Q36700611 | Mutational analysis of the equine infectious anemia virus Tat-responsive element |
Q24568366 | Novel mechanism and factor for regulation by HIV-1 Tat |
Q39719048 | Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin |
Q40043226 | Orientation-specific cis complementation by bulge- and loop-mutated human immunodeficiency virus type 1 TAR RNAs. |
Q35222971 | Peptide models of the tat—Tar protein‐RNA interaction |
Q28574911 | Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA |
Q40394774 | Phosphorylation of a chloroplast RNA-binding protein changes its affinity to RNA |
Q45755417 | Positive selection system to screen for inhibitors of human immunodeficiency virus-1 transcription |
Q36810917 | Preventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcription |
Q71144400 | Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking |
Q34768506 | Quantification of DNA-protein interaction by UV crosslinking |
Q99417440 | RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges |
Q74781345 | RNA-Binding Characteristics of a Ribonucleoprotein from Spinach Chloroplast |
Q40402003 | RNA-binding activities of the different domains of a spinach chloroplast ribonucleoprotein |
Q40467663 | Regulation of HIV-1 Gene Expression by the Transactivator Protein Tat |
Q40365664 | Regulation of eukaryotic gene expression by transcriptional attenuation |
Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
Q24651506 | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors |
Q24606166 | Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen |
Q33900660 | Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro |
Q28285441 | Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors |
Q41683806 | Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro |
Q40472923 | Solution structure of the 5'-terminal hairpin of the 7SK small nuclear RNA. |
Q35059684 | Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription |
Q42848859 | TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation |
Q40046655 | TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. |
Q40062345 | TAR-independent replication of human immunodeficiency virus type 1 in glial cells |
Q36639281 | TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein |
Q37059502 | Tat and Rev: positive modulators of human immunodeficiency virus gene expression |
Q36481470 | Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells |
Q28189849 | The apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pair |
Q36649447 | The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. |
Q40597354 | The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression |
Q36679792 | The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase |
Q37548928 | The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA |
Q37506941 | The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation |
Q34462285 | The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription |
Q24319734 | The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes |
Q40526004 | Transactivation of heterologous promoters by HIV-1 tat. |
Q24533266 | Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages |
Q35070466 | Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe |
Q40825617 | Transcriptional antitermination |
Q36797785 | Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation-responsive region of human immunodeficiency virus type 1 in vitro |
Q39870080 | Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. |
Q24681560 | Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication |
Q38330641 | Unusual structure of the human immunodeficiency virus type 1 trans-activation response element |
Q35026881 | Viral-host interactions that control HIV-1 transcriptional elongation |
Search more.